Physician profile
Jordan Carlton Schramm
NPI 1588976328
$180,527.35
in general payments reported to CMS, 2019-2025
22 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $36.64 · 2021: $22.97 · 2022: $16K · 2023: $32K · 2024: $58K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $97K · Consulting Fee: $37K · Travel and Lodging: $24K · Food and Beverage: $5,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $97,321.25 |
| Consulting Fee | $36,665.00 |
| Travel and Lodging | $24,181.70 |
| Food and Beverage | $5,286.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $178,911.00 | 2020-2025 | Tula, Coblation, Halo |
| Med-El Corporation | $881.19 | 2019 | |
| Kls-Martin L.P. | $217.92 | 2025 | |
| Depuy Synthes Sales INC. | $79.30 | 2022 | |
| Cochlear Americas | $58.07 | 2019-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Optinose US, INC. | $51.79 | 2020-2022 | |
| Ani Pharmaceuticals, INC. | $41.18 | 2022 | |
| Medical Device Business Services, INC. | $34.10 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $27.87 | 2025 | Tezspire |
| Kaleo, INC. | $27.36 | 2023 | Auvi-Q |
| Genzyme Corporation | $22.32 | 2025 | |
| Cmp Pharma, INC. | $20.64 | 2023 | Norliqva, Carospir, Tadliq |
| Integra Lifesciences Corporation | $19.65 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Baxter Healthcare | $19.23 | 2019 | |
| Medtronic, INC. | $16.96 | 2024 | Propel |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $16.46 | 2023 | Prolastin-C Liquid |
| Amneal Pharmaceuticals LLC | $15.85 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.65 | 2023 | Acthar |
| Stryker Corporation | $13.95 | 2022 | |
| Janssen Biotech, INC. | $13.35 | 2020 | |
| Glaxosmithkline, LLC. | $12.96 | 2022 | |
| Merck Sharp & Dohme LLC | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Schramm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.